Adaptive Immunity and the Risk of Autoreactivity in COVID-19
While first and foremost considered a respiratory infection, COVID-19 can result in complications affecting multiple organs. Immune responses in COVID-19 can both protect against the disease as well as drive it. Insights into these responses, and specifically the targets being recognised by the immu...
Main Authors: | Rhiane Moody, Kirsty Wilson, Katie L. Flanagan, Anthony Jaworowski, Magdalena Plebanski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8965 |
Similar Items
-
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry
by: Darja Kanduc
Published: (2020-07-01) -
Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins’ Mimicry of Human Protein Interactions
by: Hale Yapici-Eser, et al.
Published: (2021-03-01) -
A Bioinformatics Analysis Reveals Novel Pathogens as Molecular Mimicry Triggers of Systemic Sclerosis
by: Athanasios Gkoutzourelas, et al.
Published: (2019-01-01) -
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases
by: Aristo Vojdani, et al.
Published: (2021-01-01) -
Anti-microbial Antibodies, Host Immunity, and Autoimmune Disease
by: Peilin Zhang, et al.
Published: (2018-05-01)